AI Compute Demand in Biotech:  2025 Report & Statistics

 

AI-Driven Biotechnology Is Reshaping Research Through Explosive Compute Demand, Infrastructure Strain, and Strategic Investment

The biotechnology industry is experiencing a profound shift as artificial intelligence and machine learning become central to research and development. Applications spanning genomics, proteomics, drug discovery, and biological engineering are dramatically increasing computational requirements, far exceeding traditional bioinformatics workloads. This surge in AI-driven research is placing unprecedented pressure on data-center infrastructure, energy supply, and global power grids. Major pharmaceutical investments, high-profile AI breakthroughs, and expanding biotech–AI partnerships highlight both the opportunity and the strain created by this transformation. As compute demand accelerates faster than available infrastructure, the sector faces critical decisions around energy efficiency, capital investment, and long-term sustainability that will shape the future of biotech innovation.